DEFINED BENEFIT PENSION ACCOUNTING AND MARKET VALUE PER SHARE OF QUOTED PHARMACEUTICAL FIRMS IN NIGERIA

The study examineddefined benefit pension accounting and market value per share of quoted pharmaceutical companies in Nigeria. The research design adopted for this study was the ex-post facto design to investigate the relationship between Defined Benefit Pension Accounting and Market Value Per Share of Quoted Pharmaceutical Companies in Nigeria. The data used in this research were secondary data sourced from yearly account reports of these pharmaceutical companies named in Nigeria stock exchange fact books for time period of eleven years ranging from year 2011 to 2021. The sample size was three quoted pharmaceutical firms that have been trading consistently with the said period, while population was all the nine quoted pharmaceutical companies listed on the Nigeria stock exchange group. The Statistical tools used to analyze the data were descriptive Statistics, PPM correlation index, OLS and MRT as contained in SPSS package version were used to analyze the data and test research hypotheses.Secondary data was used to analysis the variables under study andthe study concluded that; there is a significant relationship between benefit service cost and market value per share which suggest that benefit service cost, as a proxy for independent variable (i.e.  defined pension accounting) has impact on the market price per share of quoted pharmaceutical firms in Nigeria.Based on the foregoing, his study recommends that organization, especially the quoted pharmaceutical firms in Nigeria, should ensure that they improve their benefit service cost in order to boost their market value per share